Mahi Drugs Private Limited - Company Profile

It is a pharma private limited company based in Vishakhapatnam, Andhra Pradesh, India, established in 2012.
2012 Vishakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Mahi Drugs Private Limited

Mahi Drugs Private Limited, a active private limited company, was established on 17 December 2012 in Vishakhapatnam, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233AP2012PTC084875. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹7.07 Cr.

It upholds a compliant status. Employing 201 professional, Its leadership includes Madhu Rao Maganty (Nominee Director), Venkata Praveen Talluri (Managing Director), Veeravenkata Satyanarayana Murthy Talluri (Director). Past directors included Madhu Rao Maganty, Venkata Praveen Talluri, Venkata Chaitanya Gopineedi. It holds ₹26.76 Cr open charges and ₹7.07 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.82, Jawaharlal Nehru Pharma City Parawada, Vishakhapatnam, Andhra Pradesh, 531019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233AP2012PTC084875

  • Registration Number

    084875

  • Incorporation Date

    17 December 2012

  • Authorized Capital

    ₹7.50 Cr

  • Paid-Up Capital

    ₹7.07 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 Cr
  • Paid Up Capital ₹ 7.07 Cr
  • Company Age 13 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 26.76 Cr
  • Satisfied Charges ₹ 7.07 Cr
  • Revenue Growth **** 9.49%
  • Profit Growth **** -162.41%
  • Ebitda **** 294.33%
  • Net Worth 28.79%
  • Total Assets **** 21.21%
Company report

Mahi Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mahi Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Mahi Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Madhu Rao Maganty Nominee Director 28 May 2022 Current
Venkata Praveen Talluri Managing Director 25 Jul 2020 Current
Veeravenkata Satyanarayana Murthy Talluri Director 07 Apr 2018 Current
Sarath Kumar Pakalapati Director 09 Aug 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 25 Sep 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2020 Past
Pramod Abcsdd Additional Director 28 Sep 2021 Past
Pramod Abcsdd Director 25 Jul 2020 Past
Pramod Abcsdd Director 28 Feb 2015 Past
Pramod Abcsdd Additional Director 03 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mahi Drugs.

Mahi Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.49% increase. The company also saw a substantial fall in profitability, with a 162.41% decrease in profit. The company's net worth Soared by an impressive increase of 28.79%.

Mahi Drugs revenue growth over time
Mahi Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.49%
*******
*******
*******
*******
Revenue from Operations
*******
 10.71%
*******
*******
*******
*******
Total Assets
*******
 21.21%
*******
*******
*******
*******
Profit or Loss
*******
 -162.41%
*******
*******
*******
*******
Net Worth
*******
 28.79%
*******
*******
*******
*******
EBITDA
*******
 294.33%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mahi Drugs?

In 2023, Mahi Drugs had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹267,640,000.00

Satisfied Charges

₹70,700,000.00

Charges Breakdown by Lending Institutions
  • Others : 26.76 Cr
Latest Charge Details
Date Lender Amount Status
20 Jul 2019 Others ₹7.50 Cr Open
21 Jun 2019 Others ₹19.26 Cr Open
17 Aug 2020 Others ₹1.92 Cr Satisfied
30 Jan 2016 Hdfc Bank Limited ₹2.95 Cr Satisfied
06 Jan 2016 Hdfc Bank Limited ₹2.20 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Mahi Drugs?

Mahi Drugs has a workforce of 201 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mahi Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahi Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mahi Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Mahi Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Mahi Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.

  • Charges

    A charge registered on 17 Aug 2020 via Charge ID 100359037 with Others was fully satisfied on 28 Feb 2025. was recorded as a recent event.

  • Director Appointment

    Sarath Kumar Pakalapati was appointed as a Director was appointed as a Director on 09 Aug 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.

  • Director Appointment

    Madhu Rao Maganty was appointed as a Nominee Director was appointed as a Nominee Director on 28 May 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 1.92 Cr registered on 17 Aug 2020 with Charge ID 100359037 was modified on 12 Oct 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mahi Drugs Private Limited?

The CIN of Mahi Drugs Private Limited is U24233AP2012PTC084875.

Where is Mahi Drugs Private Limited headquartered?

Mahi Drugs Private Limited is headquartered at Plot No.82, Jawaharlal Nehru Pharma City Parawada, Vishakhapatnam, Andhra Pradesh, 531019.

When was Mahi Drugs Private Limited incorporated?

Mahi Drugs Private Limited was incorporated on 17 December 2012.

Who are the current directors of Mahi Drugs Private Limited?

The current directors of Mahi Drugs Private Limited are

What is the primary industry of Mahi Drugs Private Limited?

The primary industry of Mahi Drugs Private Limited is Manufacturing.

Is Mahi Drugs Private Limited a listed company?

Mahi Drugs Private Limited is unlisted.

What is the capital structure of Mahi Drugs Private Limited?

The authorized capital of Mahi Drugs Private Limited is ₹7.50 Cr, and the paid-up capital is ₹7.07 Cr.

What is the compliance status of Mahi Drugs Private Limited?

The compliance status of Mahi Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available